Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schroeder Theodore R
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   22,996    

Indirect Shares

   117,489      
Direct Value   $380,610    

Indirect Value

   $46,267      
Total Shares   140,485      
Total Value   $426,877      


Collegium Pharmaceutical, Inc $375,889 Nabriva Therapeutics AG $4,721 Collegium Pharmaceutical, Inc $375,889 Nabriva Therapeutics AG $4,721
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -100.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cadence Pharmaceuticals Inc CADX President, CEO, Director 2014-03-19 0 2014-03-19 0    Premium*  
            Hyperion Therapeutics Inc HPTX Director 2015-05-07 0 2014-08-13 0    Premium*  
            Collegium Pharmaceutical, Inc COLL Director 2020-05-20 11,007 2018-05-24 0    Premium*  
            Nabriva Therapeutics AG NBRV Director 2023-01-29 11,989 2019-08-27 117,489    Premium*  
* Premium Members only  

Records found :    90         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2019-07-25 4 A $0.00 $0 I/I 6,748 67,489 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2019-08-27 4 B $1.79 $89,500 I/I 50,000 117,489 2.66 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-01-31 4 D $1.35 $21,973 D/D (16,276) 302,760 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-02-06 4 A $0.00 $0 D/D 343,800 646,560 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-02-28 4 D $1.35 $1,635 D/D (1,211) 651,108 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-03-31 4 D $0.58 $696 D/D (1,211) 649,897 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-04-30 4 D $0.55 $664 D/D (1,211) 648,686 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-05-31 4 D $1.14 $1,381 D/D (1,211) 653,662 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-06-30 4 D $0.67 $817 D/D (1,211) 652,451 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-07-31 4 D $0.76 $920 D/D (1,211) 651,240 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-08-31 4 D $0.62 $750 D/D (1,211) 650,029 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-09-30 4 D $0.53 $645 D/D (1,211) 648,818 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-10-31 4 D $0.50 $600 D/D (1,211) 647,607 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-11-30 4 D $0.43 $517 D/D (1,211) 646,396 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-12-31 4 D $2.42 $293 D/D (121) 64,518 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-01-29 4 A $0.00 $0 D/D 117,500 182,018 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-01-31 4 D $2.62 $328 D/D (125) 181,893 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-02-06 4 D $2.90 $7,816 D/D (2,695) 178,985 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-02-28 4 D $2.39 $253 D/D (106) 181,787 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-03-06 4 D $1.79 $403 D/D (225) 178,760 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-03-31 4 D $1.66 $178 D/D (107) 181,680 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-04-06 4 D $1.73 $389 D/D (225) 178,535 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-04-30 4 D $1.78 $190 D/D (107) 178,428 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-05-06 4 D $1.49 $335 D/D (225) 178,203 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-05-31 4 D $1.38 $148 D/D (107) 178,096 0 -
  90  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us